Free Trial

Jyong Biotech (MENS) Competitors

$7.94 -1.68 (-17.46%)
As of 07/3/2025 01:00 PM Eastern

MENS vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUW

Should you be buying Jyong Biotech stock or one of its competitors? The main competitors of Jyong Biotech include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

Jyong Biotech vs. Its Competitors

180 Life Sciences (NASDAQ:ATNFW) and Jyong Biotech (NASDAQ:MENS) are both pharmaceutical products companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and earnings.

In the previous week, Jyong Biotech had 2 more articles in the media than 180 Life Sciences. MarketBeat recorded 2 mentions for Jyong Biotech and 0 mentions for 180 Life Sciences. 180 Life Sciences' average media sentiment score of 0.00 beat Jyong Biotech's score of -0.50 indicating that 180 Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
180 Life Sciences Neutral
Jyong Biotech Negative

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Jyong Biotech N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Jyong BiotechN/AN/AN/AN/AN/A

Summary

180 Life Sciences and Jyong Biotech tied by winning 1 of the 2 factors compared between the two stocks.

Get Jyong Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for MENS and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MENS vs. The Competition

MetricJyong BiotechPharmaceutical Preparations IndustryManufacturing SectorNASDAQ Exchange
Market Cap$731.39M$813.43M$2.24B$8.95B
Dividend YieldN/A4.84%2.65%4.08%
P/E RatioN/A1.1022.8720.24
Price / SalesN/A220.4052.20125.29
Price / CashN/A23.44N/A57.47
Price / BookN/A6.10165.675.67
Net IncomeN/A-$27.81M-$241.20M$248.47M
7 Day PerformanceN/A0.76%1.55%3.29%
1 Month PerformanceN/A8.10%3.28%5.18%
1 Year PerformanceN/A7.76%24.32%21.35%

Jyong Biotech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MENS
Jyong Biotech
N/A$7.94
-17.5%
N/AN/A$731.39MN/A0.0031High Trading Volume
ATNFW
180 Life Sciences
N/A$0.01
-4.8%
N/A-19.8%$0.00N/A0.007Positive News
Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.01
flat
N/AN/A$0.00N/A0.002
AIMDW
Ainos
N/A$0.14
-6.7%
N/AN/A$0.00$106.21K0.0040Positive News
Gap Up
ALVOW
Alvotech
N/A$1.70
flat
N/A-47.3%$0.00$585.60M0.004Positive News
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.02
-0.5%
N/A-74.1%$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.11
+16.9%
N/A+175.9%$0.00$38.00M0.0070Positive News
Gap Up
BTMDW
biote
N/A$0.01
-31.5%
N/AN/A$0.00$199.38M0.00N/AGap Up
BCTXW
BriaCell Therapeutics
N/A$0.06
-15.6%
N/A-70.4%$0.00N/A0.008Gap Down
CELUW
Celularity
N/A$0.04
flat
N/A+100.0%$0.00$54.22M0.00220Positive News

Related Companies and Tools


This page (NASDAQ:MENS) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners